The purpose of this study is to examine whether monthly oral administration of ibandronate to
postmenopausal osteoporosis patients with type 2 diabetes differs in safety and efficacy
compared to patients without diabetes.
Phase:
N/A
Details
Lead Sponsor:
Yeouido St. Mary's Hospital
Collaborators:
Samsung Medical Center Seoul National University Bundang Hospital